Since we have first introduced preimplantation HLA typing more than 16 years ago, it has become a practical option for stem cell transplantation treatment of congenital and acquired bone marrow failures. This paper summarises our experience of 390 preimplantation HLA typing, representing a part of preimplantation genetic diagnosis (PGD) series, which is the world's largest PGD experience, involving PGD for approximately 500 genetic conditions. The proportion of PGD cases performed combined with HLA typing is steadily increasing, with iimproved awareness of at risk couples regarding PGD as a realistic option for radical treatment of their affected children with bone marrow failures. Preimplantation HLA typing involves detection and transfer of HLA matched unaffecetd embryos, to obtain an HLA compatible offspring as potential donors for their affected siblings. Available results of HLA matched stem cell transplantation treatment following PGD shows a successful hematopoietic reconstitution of patients with different conditions, suggesting that PGD is an efficient approach for HLA matched stem cell transplantation treatment of congetital and acquired bone marrow failures.